- Home
- FBRX vs MSD Comparison
FBRX vs MSD Comparison
Compare FBRX & MSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- MSD
- Stock Information
- Founded
- FBRX N/A
- MSD 1993
- Country
- FBRX United States
- MSD United States
- Employees
- FBRX N/A
- MSD N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- MSD Trusts Except Educational Religious and Charitable
- Sector
- FBRX Health Care
- MSD Finance
- Exchange
- FBRX Nasdaq
- MSD Nasdaq
- Market Cap
- FBRX 154.5M
- MSD 154.7M
- IPO Year
- FBRX N/A
- MSD N/A
- Fundamental
- Price
- FBRX $14.37
- MSD $7.34
- Analyst Decision
- FBRX Strong Buy
- MSD
- Analyst Count
- FBRX 3
- MSD 0
- Target Price
- FBRX $68.00
- MSD N/A
- AVG Volume (30 Days)
- FBRX 103.4K
- MSD 70.2K
- Earning Date
- FBRX 11-13-2025
- MSD 01-01-0001
- Dividend Yield
- FBRX N/A
- MSD 11.26%
- EPS Growth
- FBRX N/A
- MSD N/A
- EPS
- FBRX N/A
- MSD N/A
- Revenue
- FBRX N/A
- MSD N/A
- Revenue This Year
- FBRX N/A
- MSD N/A
- Revenue Next Year
- FBRX N/A
- MSD N/A
- P/E Ratio
- FBRX N/A
- MSD N/A
- Revenue Growth
- FBRX N/A
- MSD N/A
- 52 Week Low
- FBRX $4.11
- MSD $6.11
- 52 Week High
- FBRX $28.68
- MSD $7.46
- Technical
- Relative Strength Index (RSI)
- FBRX 57.28
- MSD 37.74
- Support Level
- FBRX $13.90
- MSD $7.29
- Resistance Level
- FBRX $15.49
- MSD $7.43
- Average True Range (ATR)
- FBRX 1.39
- MSD 0.06
- MACD
- FBRX -0.04
- MSD -0.02
- Stochastic Oscillator
- FBRX 46.66
- MSD 19.31
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
About MSD Morgan Stanley Emerging Markets Debt Fund Inc.
Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.